Bibliografisk note

Funding Information:
. reports grant support from ITN070AD, (Impact of Ad Libitum Peanut Consumption and Genetics in LEAP Participants and Families: LEAP Participant, Sibling and Parent Cohorts (LEAP Trio)," subaward FY21ITN280 (between Benaroya Research Institute at Virginia Mason and GSTT). S.R

Funding Information:
is committee member of IFPIES, Annals of Allergy, Asthma and Immunology, and American Board of Allergy and Immunology; received grant support from DBV Technologies, Regeneron, Alladapt; and consulting fees from Aquestive; speaker's honoraria from Nestle, Danone, and ThermoFisher Sci; A. N‐W.

Funding Information:
. is a member of the Food allergy working group of the French Society of Allergology; reports grant support from Novartis; received speaker's honoraria from Stallergenes Greer, Novartis, ALK, and ThermoFisher; M.M

Funding Information:
. reports grant support from Austrian Science Fund (FWF), Danube Allergy Research Cluster funded by the Country of Lower Austria; author Royalties from UpToDate Inc. (Wolters Kluwer Health); and lecturer's honorarium from Imperial College London, “Allergy Master of Sciences Programme” H.B

Funding Information:
reports grants from Australian NHMRC Aus Pollen Partnership (GNT1116107); Abionic SA (Switzerland) co‐funding of collaboration research grant from NFMRI; and patent: US PTO 14/311944 owned by QUT; AU2008/316301 owned by QUT; R.C.

Funding Information:
board member of HESI Protein Allergenicity and Toxins Bioinformatics Committee; holds stock options for Anagany Inc; received grants from Dutch Science Foundation; Health Holland; Angany Inc.; consulting fees from HAL Allergy BV; Citeq Inc., Anagany Inc., Reacta Healthcare Ltd, Mission MightyMe, and AB Enzymes; speaker's honoraria from ThermoFisher Sci. HAL Allergy BV and ALK; travel support from Anagany Inc. R.vR.

Funding Information:
. reports grant support from Danube Allergy Research Cluster funded by Country of Lower Austria; and is a member of the advisory board from Allergios; C.Ha

Funding Information:
reports grant support from Ulrich Muller Gierock Foundation; consulting fees from DBV, Nestle, Danone, Novartis, Abbott, Alexeia and ThermoFisher; travel support from EAACI, ThermoFisher; royalties from upToDate; Elsevier; speaker's honoraria from TF, Abbott; ALK; and holds stock options from DBV Technologies; P.A.E.

Funding Information:
is supported by the Johns Hopkins University School of Medicine faculty Scholarship; R.G. H.

Funding Information:
is member of the Scientific Board of the German Society for Allergology and Clinical Immunology (DGAKI); Executive Committee of the WHO/IUIS Allergen Nomenclature Subcommittee; editorial Board Member of the Journal “Allergy.” She reports grants from the German Research Foundation: DFG JA 1007/2‐3; Federal Ministery of Education and Science: DZL: German Center for Lung Research; AA‐FPB;FKZ:01EA2109B; Verbundprojekt ImprovNgDIagnostiCs and Therapy; INDICATE‐FH BMEL and BLE AptaSens; has received consulting fees from Frauenhofer Zukunftsstiftung; and files for Patent: Project 14‐00142 (Basophil‐Activation Test), pending; U.J.

Funding Information:
is board member of BSACI Paediatric Allergy Group and President Elect of the Royal Society of Medicine; She reports grants from NIH Seal Study and Aimmune; royalties from Wiley Rapid Paediatrics and Speaker's honoraria from DBV Technologies, Sanofi, and GSK; travel support from EAACI, BSACI; and is in the advisory board of SEED Study and IREACH Study; He.Bro.

Funding Information:
is nonexecutive Director from Reacta Biotech Ltd until November 2019; Member of the Food Standards Agency Advisory Committee on Novel Foods and Processes; and holds founder shares of Reacta Biotech Ltd; she reports grants from Reacta B UK Research and Innovation – Innovate, Swindon, UK, Biotech Ltd, European Food Safety Authority, Food Standards Agency, London, UK; consultancy fees received from Reacta Biotech Ltd; travel support from Romer Laboratories UK Ltd to attend CIFSQ, Shanghai, China, Dec 2019; and is patent holder Int. Patent Application (PCT); Oral Food Challenge Meal Formulations—Kit for allergy diagnosis. Application number:PCT/GB2016/051637; Int. Patent application (PCT): Oral Food Challenge Meal Formulations: Kits comprising placebo and nonplacebo oral food challenge meal formulations. Application number: PCT/GB2016/053829; C.M.

Funding Information:
received grant support from the Ministry of Science of the Republic of Colombia (Grants 756‐2017, 806‐2018) and reports speaker's honorarium from Sanofi at scientific events; N.A.

Funding Information:
received grants from Thermo Fisher Sci., Bencard Allergie GmbH, Allergy Therapeutics plc, and Leti Pharma; consulting fees from Bencard Allergie GmbH and speaker honoraria from DGAKI, Bencard; Allergie GmbH, and Thermo Fisher Sci. S.B.

Funding Information:
advisory board member from Deutscher Allergie‐ und Asthmabund eV, DAAB; German Federal Office of Consumer Protection and Food Safety; Senate Commission on Food Safety of the German Research Foundation, DFG‐SKLM; International Life Sciences Institute, ILSI Europe; received grants from European Dir. for the Quality of Medicines and Health Care; EU‐COST Action ImpARAS; German Federal Ministry of Food and Agriculture; and obtained travel support from Food Allergy Forum April,2019, Bastiaanse‐communication, Bilthoven, NL; T.Ho. is

Funding Information:
is the Chair of Allergy Diagnosis and Systems Medicine Interest Group of EAACI and receives grants from Fonds National de la Recherche, Luxembourg and has a research collaboration with MacroArray Diagnostics; received speaker's honorarium from ALK and travel support from HAL Allergy. C.H.

Funding Information:
. is employed by InBio Inc; she reports grant from NIH Award Number R01AI077653 (to AP); received speaker's honorarium from ThermoFisher Sci. A.P

Funding Information:
is Chair of the EAACI interest group Food Allergy and has received grants from MRC UK, NIH USA, FARE USA; Asthma UK, Rosetrees Trust, Wellcome Trust, and BBSRC; reports consulting fees from IgGenix, Novartis, Allergy Therapeutics; and Stallergenes; Speaker's honoraria from Novartis, ThermoFisher, Nutricia, Buhlmann, and Nestle and is in the advisory board from Allergy Therapeutics; A.F.S.

Funding Information:
. reports grant support from Hycor Biomedical; E.P

Funding Information:
is Vice president of Science EAACI; he reports grant support from Fonds National de la Recherche Luxembourg, consulting fees from Hycor Biomedical; speaker's honoraria from Hycor Biomedical, ThermoFisher Sci. Phadia, consulting fees from the Ministry of Health, Government of Luxembourg; travel support from EAACI for annual congresses; patents pending: WO2019/076478Al; WO2019/076477Al; scientific co‐founder ofTolerogenics SARL, Esch‐sur‐Alzette; M.O.

Funding Information:
is the Chair of EAACI Scientific Media Communications Committee (til 2022/07) and reports research grants from Euroimmun Labordiagnostika, consulting fees from Leti Pharma, Bencard Allergie GmbH and OMRON Healthcare Technologies Co. Ltd and has received speaker's honoraria from Bencard Allergie GmbH; and Allergopharma and is in the advisory board from Bencard Allergie GmbH. S.D.

Funding Information:
is the current treasurer of the Danish Society of Allergology; he reports grant from the Danish Innovation Funds; and is filing Patent 74490PC01; has received travel support from AAAAI; H.J.H.

Publisher Copyright:
© 2023 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.